Medicare AdvantagePrior AuthHigh impact
Qulipta (atogepant) (Revised)
Humana·Neurology, Pain Management·Medicare Advantage
We identified it
Jul 23, 2026
Summary
Unable to provide complete analysis. This policy update for Qulipta (atogepant) Prior Authorization for Medicare Advantage members was identified as very recent (1 day old), but the actual policy content is not accessible—only a summary-level reference is available. The source URL points to a Humana document management system that requires direct access. To properly analyze this change, the full policy document content must be retrieved.
Action Required
URGENT: Obtain the complete policy document from the source URL (https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a5847ec) or contact Humana directly to retrieve full policy details including: (1) specific effective date, (2) prior authorization requirements and triggers, (3) clinical criteria for approval, (4) applicable CPT/HCPCS codes for atogepant administration and related services, (5) any carve-outs or exceptions. Once full content is obtained, immediately update billing software with new prior auth rules, notify providers of documentation requirements, and brief front desk staff on verification procedures. High priority: Qulipta is a branded migraine preventive medication with frequent billing/authorization issues.